Form 4: Outset Medical Executive Reports Tax-Related Stock Sale
Statement of Changes in Beneficial Ownership
EVP of Operations, R&D & Service Marc Nash sold 1,582 shares of Outset Medical to cover tax obligations related to RSU vesting.
Summary
- Marc Nash, EVP of Operations, R&D & Service at Outset Medical, Inc., sold 1,582 shares of common stock on May 15, 2026.
- The shares were sold at a price of $3.70 per share.
- The transaction was a mandatory 'sell to cover' to satisfy tax withholding obligations resulting from the vesting of restricted stock units (RSUs).
- Following the transaction, the reporting person holds 38,393 shares of common stock.
- The filing includes a correction to a previous Form 4 filed on February 19, 2026, regarding the number of shares sold in a prior tax-related transaction.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the transaction is a routine administrative requirement for tax compliance rather than a strategic move.
Positives
- The transaction was non-discretionary, indicating it was not a signal of management's outlook on the company's future performance.
Negatives
- The filing highlights an administrative error in a previously filed Form 4, necessitating a correction to historical share balance reporting.
Risks
- Administrative errors in regulatory filings can lead to increased scrutiny or potential compliance concerns.
Future Outlook
No forward-looking guidance or strategic outlook provided in this filing.
Management Comments
- The sale was made to satisfy tax withholding obligations through a 'sell to cover' transaction and does not represent a discretionary trade.
Industry Context
StockSavvy.ai notes that 'sell to cover' transactions are standard practice for executives receiving equity-based compensation and generally do not reflect management sentiment regarding company health.
Comparison to Industry Standards
- The use of 'sell to cover' transactions is a standard industry practice for medical device companies and broader corporate governance to manage tax liabilities associated with RSU vesting.
Stakeholder Impact
- Minimal impact on shareholders as the transaction was non-discretionary and related to tax obligations.
Next Steps
- None mentioned.
Key Dates
| Date | Description |
|---|---|
| 07/24/2023 | Grant date of initial RSUs. |
| 01/12/2024 | Grant date of additional RSUs. |
| 06/10/2025 | Grant date of additional RSUs. |
| 02/19/2026 | Date of original Form 4 filing containing the administrative error. |
| 05/15/2026 | Date of the reported stock sale transaction. |
| 05/19/2026 | Date of the current Form 4 filing. |
Keywords
Outset Medical, OM, Insider Trading, Form 4, Tax Withholding, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.